TAMMY SASSE: Open Payments
NPI 1609322585 · ALTAMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 62 payments from 13 companies in 2025. Trend: 2023 $609 · 2024 $1,018 · 2025 $1,255
Food & beverage: $1,217Education: $39
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $267 |
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| ABBVIE INC. | 12 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $135 |
| Novartis Pharmaceuticals Corporation | 1 | $135 |
| Lundbeck LLC | 3 | $81 |
| Exact Sciences Corporation | 3 | $64 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: Wegovy, CAPLYTA, LEQVIO, BREZTRI, REXULTI, VRAYLAR, Rybelsus, QULIPTA.
Industry payments across IL — which companies pay providers there.
